$EL

Raymond James Names Top 3 Picks in Beauty Stocks

Raymond James identified Estée Lauder (EL) and Ulta (ULTA) as top beauty sector picks, citing their strategic advantages. Estée Lauder returned to growth in fiscal 2026, led by fragrance and China recovery, while Ulta showed resilience and raised its full-year guidance. E.l.f. Beauty (ELF) was noted for its value-end portfolio and growth in Rhode and international markets. Raymond James expects these companies to navigate current market conditions effectively.

Original reporting
Published Oct 21, 2026, 7:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 7:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EL
Bullish
medium confidence
Mentioned
$EL · $ULTA · $ELF
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ELBullishMed
01

Why it matters

The recommendations could shift short‑term sentiment and attract new capital to the highlighted names.

02

Market read

Analyst upgrades are fresh catalysts that can move the stocks in the short term.

03

What to watch

Potential headwinds from slowing consumer spending and supply‑chain constraints.

Relevance 5/10Novelty 6/10Timing: today

Background

Analyst Raymond James released its top three beauty stock picks, providing new coverage and upgrades.

Company-level read

Ticker impact

$ELBullishMedium confidence
Context

Raymond James named Estée Lauder as a top beauty pick, citing growth in fragrance and China recovery.

Expected impact

likely upward pressure as investors price in the upgrade and growth outlook

Evidence & confidence

The recommendation highlights new profit growth guidance for fiscal 2027, a fresh catalyst for the stock.

$ULTABullishMedium confidence
Context

Ulta was upgraded to Strong Buy by Raymond James, with expectations of faster growth after a resilient quarter.

Expected impact

potential price rise as the market absorbs the upgrade and guidance lift

Evidence & confidence

The analyst cites improved guidance and market share gains, providing a new actionable signal.

$ELFBullishMedium confidence
Context

e.l.f. Beauty was highlighted as a close‑behind pick, noting its value positioning and international expansion.

Expected impact

moderate upside as investors consider the growth narrative

Evidence & confidence

The analyst’s endorsement adds fresh coverage and could attract value‑focused investors.

Market effects

The picks signal optimism for the broader beauty sector, potentially lifting peers.

Positive outlook for U.S. consumer discretionary stocks.

Highlights recovery in China for premium beauty, relevant for global consumer trends.

Counterpoint

Some investors may view the upgrades as premature given flat makeup sales.

Key entities

  • Raymond James

    Provider of the analyst picks and upgrades.

Related articles

$ELLow

Judge Awards $63 Million in Fees From Estée Lauder Investor Settlement

A U.S. judge approved Estée Lauder's $210M investor settlement, setting attorneys' fees at $63M (30% of the fund). The court also approved $759,672.80 in litigation expenses and $21,995.21 in reimbursements. The settlement resolves claims of misleading shareholders about growth outlook and reliance on gray-market sales in China. The company denies wrongdoing.

$ELHighAI 9/10

Ban maker's shares jump on strong eyewear sales

EssilorLuxottica shares rose 14% after Q3 revenue of €7.49B beat expectations, driven by strong core eyewear sales. Smart glasses growth slowed, and the company provided a cautious outlook. Analysts note attractive valuations and defensive attributes, despite concerns over smart glasses competition.

$ELMed

Why is Estee Lauder stock climbing today?

Estee Lauder (EL) stock rose 2.6% in pre-market trading after Barclays upgraded it to Overweight and raised its price target to $108, citing broad recovery and strong Q4 2026 results. The company reported adjusted EPS of $0.39 and revenue of $3.63B, both beating estimates. Barclays highlighted balanced revenue growth and margin expansion potential. Bernstein SocGen maintained a Market Perform rating with a $106 target. The broader market traded modestly lower.